Skip to main content
. 2020 Sep 25;9(10):3093. doi: 10.3390/jcm9103093

Figure 1.

Figure 1

Conjunctival injection was significantly reduced in the lactoferrin (LF) with TALYMUS® group than in the placebo group (12-week treatment). Both groups were also treated with 0.1% tacrolimus ophthalmic suspension. The injection was scored as follows; 0, 1, 2, and 3 in both the eyes. Horizontal bar represents the groups while the vertical bar represents the score; conjunctival injection score changed during the 12-week treatment (3 Month–0 Month). * p < 0.01, Unpaired T test.